PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24400440-2 2013 The nonspecific probe substrate 4-methylumbelliferone (4-MU) and recombinant UGT enzymes (UGT1A9, UGT2B7) were firstly used to evaluate the inhibition of arbidol towards UGT1A9 and UGT2B7. umifenovir 154-161 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 98-104 24400440-2 2013 The nonspecific probe substrate 4-methylumbelliferone (4-MU) and recombinant UGT enzymes (UGT1A9, UGT2B7) were firstly used to evaluate the inhibition of arbidol towards UGT1A9 and UGT2B7. umifenovir 154-161 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 181-187 24400440-3 2013 Furthermore, specific substrates of UGT1A9 and UGT2B7 propofol and zidovudine (AZT) were used to determine the inhibition of arbidol towards UGT1A9 and UGT2B7. umifenovir 125-132 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 152-158 24400440-6 2013 Arbidol was demonstrated to exhibit competitive inhibition towards UGT1A9 and UGT2B7 without substate-dependent behaviour. umifenovir 0-7 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 78-84 24400440-9 2013 Given that arbidol exhibits strong inhibition towards UGT1A9 and UGT2B7, clinical monitoring should be given when arbidol was co-administered with drugs mainly undergoing UGT1A9, UGT2B7-mediated metabolism. umifenovir 11-18 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 65-71 24400440-9 2013 Given that arbidol exhibits strong inhibition towards UGT1A9 and UGT2B7, clinical monitoring should be given when arbidol was co-administered with drugs mainly undergoing UGT1A9, UGT2B7-mediated metabolism. umifenovir 11-18 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 179-185 24400440-9 2013 Given that arbidol exhibits strong inhibition towards UGT1A9 and UGT2B7, clinical monitoring should be given when arbidol was co-administered with drugs mainly undergoing UGT1A9, UGT2B7-mediated metabolism. umifenovir 114-121 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 65-71